about
Purinergic Receptors: Key Mediators of HIV-1 Infection and InflammationThe selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cellsT cell virological synapses and HIV-1 pathogenesis.Manipulating CD4+ T cells by optical tweezers for the initiation of cell-cell transfer of HIV-1.Sequence of human immunodeficiency virus type 1 (HIV-1) Gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1.Quantitative 3D video microscopy of HIV transfer across T cell virological synapsesVirological synapses allow HIV-1 uptake and gene expression in renal tubular epithelial cellsMultiploid inheritance of HIV-1 during cell-to-cell infection.Cell-to-cell transfer of HIV-1 via virological synapses leads to endosomal virion maturation that activates viral membrane fusionA high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entryHIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cellsP2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.Visualizing cell-to-cell transfer of HIV using fluorescent clones of HIV and live confocal microscopyUnique features of HIV-1 spread through T cell virological synapses.Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivityLymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid.Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cellsCD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef.Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection.IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibilityIn vivo tissue distribution of CD4 lymphocytes in mice determined by radioimmunoscintigraphy with an 111In-labeled anti-CD4 monoclonal antibody.Tracking and quantitation of fluorescent HIV during cell-to-cell transmission.Mechanisms of enhanced HIV spread through T-cell virological synapses.Cell-to-Cell Spread of HIV and Viral Pathogenesis.Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses.Inhibition of viral assembly in murine cells by HIV-1 matrix.Visualization of HIV T Cell Virological Synapses and Virus-Containing Compartments by Three-Dimensional Correlative Light and Electron Microscopy.In Vivo HIV-1 Cell-to-Cell Transmission Promotes Multicopy Micro-compartmentalized Infection.Measuring T Cell-to-T Cell HIV-1 Transfer, Viral Fusion, and Infection Using Flow Cytometry.HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail.Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individualsVariable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clonesSequential trafficking of Env and Gag to HIV-1 T cell virological synapses revealed by live imaging
P50
Q26774666-DB4A7B37-D4EF-4D1F-9C74-0FF63A9657C5Q28139452-BA4F21A7-96BF-4E25-9599-EAB8DF7281C9Q30415010-204CD8E8-1E64-44D9-85CB-6AAF23AC7589Q30475585-114C8276-B6AF-4A34-AA3B-EA78DECF99A2Q30480956-1F97ECEF-3FD0-431F-8168-4D9000167412Q30490761-E36E6413-9B66-491A-A64C-8541A2A1B6D1Q30498853-8BB94750-F0B1-473A-9ABD-8B5802A61DD7Q30501773-7581E590-6931-4AC8-A7F8-4746B978747CQ30505286-57863471-C6F1-49EE-89BC-A987ABD6555EQ30810565-C8D4E200-B2FC-401E-B391-5630E51FD5D7Q33887674-F2F0FEF3-B7F8-4FCE-A1B9-D246010933E4Q33887743-E13FC76A-9ED6-400E-A5E8-A7B449B7FC15Q33953076-E80CEEC8-3899-4C6E-AC86-3B9966EB481BQ34261784-67319F8A-7DBD-41C4-82C0-497D34A93A3BQ35260776-E076187A-B543-44A9-83CB-2E0BF1ECAD89Q35529719-DCF2D958-1DC8-4987-B3B2-A23505E41585Q35566715-3D21EC35-1058-4AD0-96AA-8C4A235F35D8Q35691047-AF491840-395E-44EC-9780-7458D5B7DD40Q35842577-5A6DEC2D-A048-4CD0-A10E-C65E68C5071DQ35868046-1EC58D60-97EE-409F-A61D-A6CEAEFE8E38Q35888785-E72C1812-6B61-46FE-AA33-647D4F37CEF6Q36150469-DA4A4919-EFB8-4689-B436-519FE89F7A5CQ37233259-59D61671-92A9-475E-AAEF-E942ED92C291Q37422181-021E66D0-53A6-46F5-9922-7D21EB67D724Q37772257-23955660-D46E-425E-B063-3F456A6E9135Q38070789-8F9415CF-27BA-4D23-9859-EDBCA88C3662Q38816960-FEB40D3C-9A3C-4735-A329-D9EA1DD9E739Q40038787-FAEA4987-4A5E-4184-81D3-0DBAA28DD864Q40272091-24CED1D3-E1FC-4389-961D-0575795CC3ADQ40450594-72FDFE2C-3EAB-4041-B920-35B3B4A076BDQ40705473-5F5F065F-91F3-47C3-98F8-04CBB6077563Q40852789-7128B139-4872-455C-993C-F7C69396017FQ41127118-95F7CF6C-BA0E-416C-AB23-855809C4C779Q57042022-52BD18D7-06B4-4F51-B4F1-E12D2E3E8127Q58591002-A5AF1B59-5F42-43E1-9F88-78A48A781596Q61448518-2BFC9C22-48FD-4BA5-8928-70B7D26B234F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Benjamin K. Chen
@ast
Benjamin K. Chen
@en
Benjamin K. Chen
@es
Benjamin K. Chen
@nl
Benjamin K. Chen
@sl
type
label
Benjamin K. Chen
@ast
Benjamin K. Chen
@en
Benjamin K. Chen
@es
Benjamin K. Chen
@nl
Benjamin K. Chen
@sl
prefLabel
Benjamin K. Chen
@ast
Benjamin K. Chen
@en
Benjamin K. Chen
@es
Benjamin K. Chen
@nl
Benjamin K. Chen
@sl
P106
P1153
7408610992
P21
P31
P496
0000-0002-5404-1997